Selank 10mg

Descrição

Selank 10mg is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) developed in Russia as a modified analog of the natural immunomodulatory tetrapeptide tuftsin, with an added Pro-Gly-Pro C-terminal sequence for increased stability, bioavailability, and duration of action. Selank acts primarily through modulation of the GABAergic system (enhancing GABA receptor affinity), inhibition of enkephalin degradation, upregulation of brain-derived neurotrophic factor (BDNF), and balanced influence on serotonin, dopamine, and norepinephrine pathways—producing calming, mood-stabilizing, and cognitive-enhancing effects without the sedation, tolerance, dependence, or withdrawal associated with benzodiazepines or many conventional anxiolytics.

Clinical studies conducted in Russia (including trials for generalized anxiety disorder, neurasthenia, and adjustment disorders) have shown Selank to significantly reduce anxiety symptoms, improve attention and memory under stress, enhance mental clarity and learning capacity, stabilize emotional responses, and offer neuroprotective benefits in models of brain injury or neurodegeneration. It also exhibits mild immunomodulatory effects, supporting balanced immune function and potentially reducing inflammation in the central nervous system.

In wellness, nootropic, and biohacking communities, Selank 10mg (typically supplied as a lyophilized 10mg vial for reconstitution) is most commonly administered as a nasal spray (200–600 mcg per nostril, 1–3 times daily) due to direct nose-to-brain delivery and high bioavailability, or via subcutaneous injection at similar microgram doses. Cycles often last 10–30 days followed by breaks. Users frequently report rapid-onset anxiolytic effects (within 10–30 minutes nasally), reduced anticipatory anxiety, better stress resilience, improved focus during demanding tasks, enhanced mood stability, clearer thinking, and better sleep quality without drowsiness or cognitive blunting.

While generally well-tolerated with minimal side effects (occasional mild nasal irritation with spray form, rare transient fatigue or headache), Selank is not FDA-approved for any therapeutic, psychiatric, cognitive enhancement, or medical use as of 2026. It remains investigational outside Russia and certain Eastern European countries where it has been used clinically under specific regulations. Human data is limited compared to Western pharmaceuticals, relying heavily on Russian studies, small trials, and widespread anecdotal evidence rather than large-scale international randomized controlled trials.

Selank 10mg should never be used without consulting a qualified healthcare provider knowledgeable in peptides or nootropics, as self-administration carries risks of improper dosing, contamination from unregulated sources, unexpected reactions, or interactions with other medications (e.g., SSRIs, anxiolytics). Prioritize evidence-based treatments for anxiety, stress, or cognitive concerns—counseling, lifestyle changes, and approved therapies—over unapproved research compounds. Consult a professional to assess suitability, source from reputable suppliers if considered under guidance, and stay informed on evolving research or regulatory status. Selank is not a substitute for proven medical interventions.

ALSO SEE